Bristol-Myers Squibb announced a seven per cent increase in revenue for the second quarter on the back of growing sales of cancer immunotherapy OPDIVO (nivolumab). …
Latest Video
New Stories
-
NDIS minister restates the importance of 'nothing about us, without us!'
May 20, 2025 - - Latest News -
Industry alarm over the sudden pursuit of surprise uncertified claims
May 20, 2025 - - Latest News -
Medicines Australia sharpens post-election language on reform
May 20, 2025 - - Latest News -
Report highlights international confidence in Australian clinical trials
May 19, 2025 - - Latest News -
Experts urge vigilance with RSV ahead of winter, saying it’s as serious in older adults as it is in babies
May 19, 2025 - - Latest News -
FDA clears the first blood test used for diagnosing Alzheimer’s Disease
May 19, 2025 - - Latest News -
New report reveals the magnitude of the challenge facing Mark Butler
May 18, 2025 - - Latest News